Amylyx Pharmaceuticals (AMLX)'s 30-day implied volatility (IV30) was 43.2% at the close on November 18, 2026, down from 46.7% the day before, against a 52-week range of 38.2% to 252.4%. Its 20-day historical volatility was 58.0%.
Data as of November 18, 2026.